Previous Page  7 / 12 Next Page
Information
Show Menu
Previous Page 7 / 12 Next Page
Page Background

Tissue Science 2019

June 17-18, 2019

London, UK

Advances in Tissue

Engineering and

Biomaterials Science

13

th

Edition of International Conference on

Journal of Biomedical Sciences

ISSN: 2254-609X

Page 23

Amniotic membrane mapping discloses novel promising

features of amniotic membrane epithelial cells for

regenerative medicine purposes

Roberta Di Pietro

G. d’Annunzio University of Chieti-Pescara, Italy

T

he amniotic membrane (AM) is the innermost part

of the placenta, in direct contact with the amniotic

fluid. In recent years the interest toward placenta stem

cells has been increasingly growing, due in part to the

absence of any ethical issues concerning their isolation.

At present, two main stem cells populations have been

identified in AM: amniotic epithelial cells (AECs) and

amniotic mesenchymal stromal cells (AMSCs). Although

AM is an excellent source of cells for regenerative

medicine, also due to its immune-modulatory properties

and low immunogenicity, only a few papers have

studied its sub-regions. Thus, our focus was to map the

human AM under physiological conditions to identify

possible differences in morpho-functional features and

regenerative capacity of its components. Human term

placentas were collected from healthy women after

vaginal delivery or caesarean section at Fondazione

Poliambulanza-Istituto Ospedaliero of Brescia, University

Hospital of Cagliari and SS. Annunziata Hospital of

Chieti. Samples of AM were isolated from four different

regions according to their position relative to umbilical

cord (central, intermediate, peripheral, reflected). By

means of immunohistochemistry, morphometry, flow

cytometry, electron microscopy, CFU assays, RT-PCR

and AECs in vitro differentiation we demonstrated the

existence of different morpho-functional features in the

different regions of AM, highlighting that AECs are a

heterogeneous cell population.This shouldbeconsidered

to increase efficiency of amniotic membrane application

within a therapeutic context.

Biography

Roberta Di Pietro got the degree in Medicine cum Laude in

1985 and the Specialization in Sports Medicine cum Laude in

1988, University of Chieti, Italy. She worked as a Visiting Scien-

tist at the Biochemistry Department, AFRC, Cambridge, UK; at

the Pathology Department, USUHS, Bethesda, USA, and at the

Institute of Human Virology, University of Maryland, Baltimore,

USA. She got the position of Full Professor of Histology and

Embryology at the University of Chieti since 2005. She joined

the Editorial Board of Current Pharmaceutical Design as an

Executive Guest Editor and, recently, the Editorial Academy of

the International Journal of Oncology as an Honorary Member.

She was recognized as a Registered Referee for Archives of

Ophthalmological Reviews and Reproductive Biology and En-

docrinology. She is now author of 200 scientific publications

plus international e-book chapters, editorials, Italian textbooks

and 1 Italian patent.

r.dipietro@unich.it

Roberta Di Pietro, J Biomedical Sci 2019, Volume 08